Benefit of early initiation of neuraminidase inhibitor treatment to hospitalized patients with avian influenza A(H7N9) virus
Clinical Infectious Diseases Mar 29, 2018
Zheng S, et al. - The significance of early neuraminidase inhibitor (NAI) therapy for treating influenza A(H7N9) is investigated. Findings reveal that in patients with H7N9 viral infection, early NAI therapy within 2 days of illness shortened the duration of viral shedding and improved survival.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
